Role of p21-activated kinase 1 in regulating the migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients

Rheumatology (United Kingdom)

Volumn 51, Issue 7, 2012, Pages 1170-1180

  Fu, Di ^a   Yang, Yanlong ^a   Xiao, Youjun ^a   Lin, Haobo ^a   Ye, Yujin ^a   Zhan, Zhongping ^a   Liang, Liuqin ^a   Yang, Xiuyan ^a   Sun, Lin ^b   Xu, Hanshi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b School of Medicine   (United States)

Author keywords

Fibroblast like synoviocytes; Invasion; Migration; P21 activated kinase 1; Rheumatoid arthritis

Indexed keywords

COLLAGENASE 3; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; P21 ACTIVATED KINASE 1; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARTILAGE; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; DISEASE MODEL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; EX VIVO STUDY; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMPLANTATION; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SCID MOUSE; SYNOVIOCYTE; SYNOVIUM; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; ANIMALS; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, SCID; MIDDLE AGED; P21-ACTIVATED KINASES; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 84863828199     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes031     Document Type: Article

References (37)

1. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344:907-16.
2. Huber LC, Distler O, Tarner I et al. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology 2006;45: 669-75.
3. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 1997;94:10895-900.
4. Roivainen A, Jalava J, Pirila L et al. H-ras oncogene point mutation in arthritic synovium. Arthritis Rheum 1997;40: 1636-43.
5. Müller-Ladner U, Pap T, Gay RE, Neidhart M, Gay S. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol 2005;1:102-10.
6. Müller-Ladner U, Kriegsmann J, Franklin BN et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
7. Pap T, Meinecke I, Muller-Ladner U, Gay S. Are fibroblasts involved in joint destruction? Ann Rheum Dis 2005; 64(Suppl. 4):iv52-4.
8. Lefèvre S, Knedlal A, Tenniel C et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009;15:1414-20.
9. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994;367:40-6.
10. Arias-Romero LE, Chernoff J. A tale of two Paks. Biol Cell 2008;100:97-108.
11. Bokoch GM. Biology of the p21-activated kinases. Annu Rev Biochem 2003;72:743-81.
12. Manser E, Huang HY, Loo TH et al. Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol 1997;17:1129-43.
13. Martin GA, Bollag G, McCormick F, Abo A. A novel serine kinase activated by Rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. EMBO J 1995;14:1970-8.
14. Kichina JV, Goc A, Al-Husein B, Somanath PR, Kandel ES. PAK1 as a therapeutic target. Expert Opin Ther Targets 2010;14:703-25.
15. Eswaran J, Lee WH, Debreczeni JE et al. Crystal Structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group II PAKs. Structure 2007;15:201-13.
16. Eswaran J, Soundararajan M, Knapp S. Targeting group II PAKs in cancer and metastasis. Cancer Metastasis Rev 2009;28:209-17.
17. Rennefahrt UE, Deacon SW, Parker SA et al. Specificity profiling of Pak kinases allows identification of novel phosphorylation sites. J Biol Chem 2007;282:15667-78.
18. Kumar R, Gururaj AE, Barnes CJ. p21-activated kinases in cancer. Nat Rev Cancer 2006;6:459-71.
19. Zhou GL, Zhuo Y, King CC et al. Akt phosphorylation of serine 21 on Pak1 modulates Nck binding and cell migration. Mol Cell Biol 2003;23:8058-69.
20. Frost JA, Xu S, Hutchison MR, Marcus S, Cobb MH. Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members. Mol Cel Biol 1996;16:3707-13.
21. Brown JL, Stowers L, Baer M et al. Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. Curr Biol 1996;6:598-605.
22. Adam L, Vadlamudi R, Mandal M, Chernoff J, Kumar R. Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1. J Biol Chem 2000;275:12041-50.
23. Huynh N, Liu KH, Baldwin GS, He H. p21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-pathways. Biochim Biophys Acta 2010;180:1106-13.
24. Ching YP, Leong VY, Lee MF et al. p21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation. Cancer Res 2007;67:3601-8.
25. Dummler B, Ohshiro K, Kumar R, Field J. Pak protein kinases and their role in cancer. Cancer Metastasis Rev 2009;28:51-63.
26. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
27. Müller-Ladner U, Evans CH, Franklin BN et al. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum 1999;42: 490-7.
28. Volin MV, Huynh N, Klosowska K, Chong KK, Woods JM. Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt. Arthritis Rheum 2007;56: 2512-22.
29. Gravallese EM, Manning C, Tsay A et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000;43:250-8.
30. Whale A, Hashim FN, Fram S, Jones GE, Wells CM. Signaling to cancer cell invasion through PAK family kinases. Front Biosci 2011;16:849-64.
31. Siu MK, Yeung MC, Zhang H et al. p21-activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease. Am J Pathol 2010;176:3015-22.
32. Delorme-Walker VD, Peterson JR, Chernoff J et al. Pak1 regulates focal adhesion strength, myosin IIA distribution, and actin dynamics to optimize cell migration. J Cell Biol 2011;193:1289-303.
33. Hinoki A, Kimura K, Higuchi S et al. p21-activated kinase 1 participates in vascular remodeling in vitro and in vivo. Hypertension 2010;55:161-5.
34. Coles LC, Shaw PE. PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway. Oncogene 2002;21:2236-44.
35. Pap T, Nawrath M, Heinrich J et al. Cooperation of Rasand c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum 2004;50:2794-802.
36. Balasenthil S, Sahin AA, Barnes CJ et al. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem 2004; 279:1422-8.
37. Zhou L, Yan C, Gieling RG et al. Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated kinase-1. BMC Immunol 2009;10:15.